Phenylalanyl-tRNA synthetase

References

• Ibba M, Söll D. Quality control mechanisms during translation. Science. 1999;286(5446):1893–1897.
   Web of Science ®Google Scholar
• Carter CW Jr. Cognition, mechanism, and evolutionary relationships in aminoacyl-tRNA synthetases. Annu Rev Biochem. 1993;62:715–748.
   PubMed Web of Science ®Google Scholar
• Ibba M, Söll D. Aminoacyl-tRNA synthesis. Annu Rev Biochem. 2000;69:617–650.
   PubMed Web of Science ®Google Scholar
• Mascarenhas AP, An S, Rosen AE, Martinis SA, Musier-Forsyth K. Fidelity mechanisms of the aminoacyl-tRNA synthetases. In: Köhrer C, RajBhandary UL, editors. Protein Engineering. Berlin: Springer-Verlag; 2009:155–203.
   Google Scholar
• Burbaum JJ, Schimmel P. Structural relationships and the classification of aminoacyl-tRNA synthetases. J Biol Chem. 1991;266(26):16965–16968.
   Web of Science ®Google Scholar
• Cusack S. Sequence, structure and evolutionary relationships between class 2 aminoacyl-tRNA synthetases: an update. Biochimie. 1993;75(12):1077–1081.
   Web of Science ®Google Scholar
• Klipcan L, Finarov I, Moor N, Safro MG. Structural aspects of phenylalanylation and quality control in three major forms of phenylalanyl-tRNA synthetase. J Amino Acids. 2010;2010:983503.
   Google Scholar
• Bullwinkle TJ, Ibba M. Emergence and evolution. Top Curr Chem. 2014;344:43–87.
   Web of Science ®Google Scholar
• Guo M, Yang XL, Schimmel P. New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol. 2010;11(9):668–674.
   PubMed Web of Science ®Google Scholar
• Peng Y, Paul LF. Aminoacyl-tRNA synthetases in medicine and disease. EMBO Mol Med. 2013;5(3):332–343.
   Web of Science ®Google Scholar
• Duchêne AM, Giritch A, Hoffmann B, et al. Dual targeting is the rule for organellar aminoacyl-tRNA synthetases in Arabidopsis thaliana. Proc Natl Acad Sci U S A. 2005;102(45):16484–16489.
   Google Scholar
• Berglund AK, Pujol C, Duchene AM, Glaser E. Defining the determinants for dual targeting of amino acyl-tRNA synthetases to mitochondria and chloroplasts. J Mol Biol. 2009;393(4):803–814.
   Google Scholar
• Jackson KE, Pham JS, Kwek M, et al. Dual targeting of aminoacyl-tRNA synthetases to the apicoplast and cytosol in Plasmodium falciparum. Int J Parasitol. 2012;42(2):177–186.
   Web of Science ®Google Scholar
• Pino P, Aeby E, Foth BJ, et al. Mitochondrial translation in absence of local tRNA aminoacylation and methionyl tRNA Met formylation in Apicomplexa. Mol Microbiol. 2010;76(3):706–718.
   Web of Science ®Google Scholar
• Jackson KE, Habib S, Frugier M, et al. Protein translation in Plasmodium parasites. Trends Parasitol. 2011;27(10):467–476.
   Web of Science ®Google Scholar
• Sharma A, Sharma A. Plasmodium falciparum mitochondria import tRNAs along with an active phenylalanyl-tRNA synthetase. Biochem J. 2015;465(3):459–469.
   Google Scholar
• Schimmel P, Tao J, Hill J. Aminoacyl tRNA synthetases as targets for new anti-infectives. FASEB J. 1998;12(15):1599–1609.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee SW, Choi EC, Choi SY. Aminoacyl-tRNA synthetases and their inhibitors as a novel family of antibiotics. Appl Microbiol Biotechnol. 2003;61(4):278–288.
   PubMed Web of Science ®Google Scholar
• Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet. 2008;9:87–107.
   PubMed Web of Science ®Google Scholar
• Eriani G, Delarue M, Poch O, Gangloff J, Moras D. Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature. 1990;347(6289):203–206.
   PubMed Web of Science ®Google Scholar
• Safro M, Moor N, Lavrik O. Phenylalanyl-tRNA synthetase. In: Ibba M, Francklyn CS, Cusack S, editors. The Aminoacyl-tRNA Synthetases, George Town: Landes Bioscience; 2004:250–265.
   Google Scholar
• Woese CR, Olsen GJ, Ibba M, Söll D. Aminoacyl-tRNA synthetases, the genetic code, and the evolutionary process. Microbiol Mol Biol Rev. 2000;64(1):202–236.
   Google Scholar
• Mosyak L, Reshetnikova L, Goldgur Y, Delarue M, Safro MG. Structure of phenylalanyl-tRNA synthetase from Thermus thermophilus. Nat Struct Biol. 1995;2(7):537–547.
   Google Scholar
• Goldgur Y, Mosyak L, Reshetnikova L, et al. The crystal structure of phenylalanyl-tRNA synthetase from Thermus thermophilus complexed with cognate tRNAPhe. Structure. 1997;5(1):59–68.
   Web of Science ®Google Scholar
• Roy H, Ibba M. Phenylalanyl-tRNA synthetase contains a dispensable RNA-binding domain that contributes to the editing of noncognate aminoacyl-tRNA. Biochemistry. 2006;45(30):9156–9162.
   Web of Science ®Google Scholar
• Moor N, Linshiz G, Safro M. Cloning and expression of human phenylalanyl-tRNA synthetase in Escherichia coli: comparative study of purified recombinant enzymes. Protein Expr Purif. 2002;24(2):260–267.
   Web of Science ®Google Scholar
• Finarov I, Moor N, Kessler N, Klipcan L, Safro MG. Structure of human cytosolic phenylalanyl-tRNA synthetase: evidence for kingdom-specific design of the active sites and tRNA binding patterns. Structure. 2010;18(3):343–353.
   Web of Science ®Google Scholar
• Shiraki K, Tsuji M, Hashimoto Y, et al. Genetic, enzymatic, and structural analyses of phenylalanyl-tRNA synthetase from Thermococcus kodakaraensis KOD1. J Biochem. 2003;134(4):567–574.
   Google Scholar
• Zykova NA, Nevinskiĭ GA, Lavrik OI. The separation of subunits of phenylalanyl-tRNA-synthetase from Escherichia coli MRE-600 by means of affinity chromatography in dissociation conditions. Mol Biol (Mosk). 1982;16(6):1165–1172.
   Web of Science ®Google Scholar
• Ducruix A, Hounwanou N, Reinbolt J, Boulanger Y, Blanquet S. Purification and reversible subunit dissociation of overproduced Escherichia coli phenylalanyl-tRNA synthetase. Biochim Biophys Acta. 1983;741(2):244–250.
   Google Scholar
• Khodyreva SN, Moor NA, Ankilova VN, Lavrik OI. Phenylalanyl-tRNA synthetase from E. coli MRE-600: analysis of the active site distribution on the enzyme subunits by affinity labelling. Biochim Biophys Acta. 1985;830(2):206–212.
   Google Scholar
• Reshetnikova L, Moor N, Lavrik O, Vassylyev DG. Crystal structures of phenylalanyl-tRNA synthetase complexed with phenylalanine and a phenylalanyl-adenylate analogue. J Mol Biol. 1999;287(3):555–568.
   Web of Science ®Google Scholar
• Moor N, Kotik-Kogan O, Tworowski D, Sukhanova M, Safro M. The crystal structure of the ternary complex of phenylalanyl-tRNA synthetase with tRNAPhe and a phenylalanyl-adenylate analogue reveals a conformational switch of the CCA end. Biochemistry. 2006;45(35):10572–10583.
   Google Scholar
• Rodova M, Ankilova V, Safro MG. Human phenylalanyl-tRNA synthetase: cloning, characterization of the deduced amino acid sequences in terms of the structural domains and coordinately regulated expression of the alpha and beta subunits in chronic myeloid leukemia cells. Biochem Biophys Res Commun. 1999;255(3):765–773.
   Google Scholar
• Sasaki HM, Sekine S, Sengoku T, et al. Structural and mutational studies of the amino acid-editing domain from archaeal/eukaryal phenylalanyl-tRNA synthetase. Proc Natl Acad Sci U S A. 2006;103(40):14744–14749.
   Web of Science ®Google Scholar
• Fasiolo F, Remy P, Pouyet J, Ebel JP. Yeast phenylalanyl-tRNA synthetase. Molecular weight and interaction with tRNAPhe and phenylalanine. Eur J Biochem. 1974;50(1):227–236.
   Google Scholar
• Diodato D, Ghezzi D, Tiranti V. The mitochondrial aminoacyl tRNA synthetases: genes and syndromes. Int J Cell Biol. 2014;2014:787956.
   Google Scholar
• Gray MW, Burger G, Lang BF. The origin and early evolution of mitochondria. Genome Biol. 2001;2(6):reviews 1018.
   PubMed Web of Science ®Google Scholar
• Martin W, Stoebe B, Goremykin V, Hapsmann S, Hasegawa M, Kowallik KV. Gene transfer to the nucleus and the evolution of chloroplasts. Nature. 1998;393(6681):162–165.
   Google Scholar
• Sanni A, Walter P, Boulanger Y, Ebel JP, Fasiolo F. Evolution ofaminoacyl-tRNA synthetase quaternary structure and activity: Saccharomyces cerevisiae mitochondrial phenylalanyl-tRNA synthetase. Proc Natl Acad Sci U S A.1991;88(19):8387–8391.
   Google Scholar
• Bullard JM, Cai YC, Demeler B, Spremulli LL. Expression and characterization of a human mitochondrial phenylalanyl-tRNA synthetase. J Mol Biol. 1999;288(4):567–577.
   Web of Science ®Google Scholar
• Baker MJ, Frazier AE, Gulbis JM, Ryan MT. Mitochondrial protein-import machinery: correlating structure with function. Trends Cell Biol. 2007;17(9):456–464.
   Web of Science ®Google Scholar
• Endo T, Yamano K. Multiple pathways for mitochondrial protein traffic. Biol Chem. 2009;390(8):723–730.
   Web of Science ®Google Scholar
• Vögtle FN, Wortelkamp S, Zahedi RP, et al. Global analysis of the mitochondrial N-proteome identifies a processing peptidase critical for protein stability. Cell. 2009;139(2):428–439.
   PubMed Web of Science ®Google Scholar
• Gakh O, Cavadini P, Isaya G. Mitochondrial processing peptidases. Biochim Biophys Acta. 2002;1592(1):63–77.
   PubMed Web of Science ®Google Scholar
• Longley MJ, Humble MM, Sharief FS, Copeland WC. Disease variants of the human mitochondrial DNA helicase encoded by C10orf2 differentially alter protein stability, nucleotide hydrolysis, and helicase activity. J Biol Chem. 2010;285(39):29690–29702.
   Web of Science ®Google Scholar
• Klipcan L, Levin I, Kessler N, Moor N, Finarov I, Safro M. The tRNA-induced conformational activation of human mitochondrial phenylalanyl-tRNA synthetase. Structure. 2008;16(7):1095–1104.
   Web of Science ®Google Scholar
• Klipcan L, Moor N, Finarov I, Kessler N, Sukhanova M, Safro MG. Crystal structure of human mitochondrial PheRS complexed with tRNA(Phe) in the active “open” state. J Mol Biol. 2012;415(3):527–537.
   Web of Science ®Google Scholar
• Yadavalli SS, Klipcan L, Zozulya A, et al. Large-scale movement of functional domains facilitates aminoacylation by human mitochondrial phenylalanyl-tRNA synthetase. FEBS Lett. 2009;583(19):3204–3208.
   Web of Science ®Google Scholar
• Cochella L, Green R. Fidelity in protein synthesis. Curr Biol. 2005;15(14):R536–R540.
   Web of Science ®Google Scholar
• Ogle JM, Ramakrishnan V. Structural insights into translational fidelity. Annu Rev Biochem. 2005;74:129–177.
   PubMed Web of Science ®Google Scholar
• Ling J, So BR, Yadavalli SS, et al. Resampling and editing of mischarged tRNA prior to translation elongation. Mol Cell. 2009;33(5):654–660.
   Web of Science ®Google Scholar
• Fersht AR. Editing mechanisms in protein synthesis. Rejection of valine by the isoleucyl-tRNA synthetase. Biochemistry. 1977;16(5):1025–1030.
   Web of Science ®Google Scholar
• Ling J, Reynolds N, Ibba M. Aminoacyl-tRNA synthesis and translational quality control. Annu Rev Microbiol. 2009;63:61–78.
   PubMed Web of Science ®Google Scholar
• Ling J, Roy H, Ibba M. Mechanism of tRNA-dependent editing in translational quality control. Proc Natl Acad Sci U S A. 2007;104(1):72–77.
   Web of Science ®Google Scholar
• Giegé R, Sissler M, Florentz C. Universal rules and idiosyncratic features in tRNA identity. Nucleic Acids Res. 1998;26(22):5017–5035.
   Web of Science ®Google Scholar
• Zhou XL, Zhu B, Wang ED. The CP2 domain of leucyl-tRNA synthetase is crucial for amino acid activation and post-transfer editing. J Biol Chem. 2008;283(52):36608–36616.
   Web of Science ®Google Scholar
• Kim HY, Ghosh G, Schulman LH, Brunie S, Jakubowski H. The relationship between synthetic and editing functions of the active site of an aminoacyl-tRNA synthetase. Proc Natl Acad Sci U S A. 1993;90(24):11553–11557.
   Web of Science ®Google Scholar
• Dock-Bregeon A, Sankaranarayanan R, Romby P, et al. Transfer RNA-mediated editing in threonyl-tRNA synthetase. The class II solution to the double discrimination problem. Cell. 2000;103(6):877–884.
   Web of Science ®Google Scholar
• Wong FC, Beuning PJ, Nagan M, Shiba K, Musier-Forsyth K. Functional role of the prokaryotic proline-tRNA synthetase insertion domain in amino acid editing. Biochemistry. 2002;41(22):7108–7115.
   Web of Science ®Google Scholar
• Gruic-Sovulj I, Rokov-Plavec J, Weygand-Durasevic I. Hydrolysis of non-cognate aminoacyl-adenylates by a class II aminoacyl-tRNA synthetase lacking an editing domain. FEBS Lett. 2007;581(26):5110–5114.
   Web of Science ®Google Scholar
• Roy H, Ling J, Irnov M, Ibba M. Post-transfer editing in vitro and in vivo by the beta subunit of phenylalanyl-tRNA synthetase. EMBO J. 2004;23(23):4639–4648.
   Web of Science ®Google Scholar
• Igloi GL, von der Haar F, Cramer F. Aminoacyl-tRNA synthetases from yeast: generality of chemical proofreading in the prevention of misaminoacylation of tRNA. Biochemistry. 1978;17(17):3459–3468.
   Web of Science ®Google Scholar
• Lin SX, Baltzinger M, Remy P. Fast kinetic study of yeast phenylalanyl-tRNA synthetase: role of tRNAPhe in the discrimination between tyrosine and phenylalanine. Biochemistry. 1984;23(18):4109–4116.
   Web of Science ®Google Scholar
• Roy H, Ling J, Alfonzo J, Ibba M. Loss of editing activity during the evolution of mitochondrial phenylalanyl-tRNA synthetase. J Biol Chem. 2005;280(46):38186–38192.
   Web of Science ®Google Scholar
• Lin SX, Baltzinger M, Remy P. Fast kinetic study of yeast phenylalanyl-tRNA synthetase: an efficient discrimination between tyrosine and phenylalanine at the level of the aminoacyladenylate-enzyme complex. Biochemistry. 1983;22(3):681–689.
   Web of Science ®Google Scholar
• Kotik-Kogan O, Moor N, Tworowski D, Safro M. Structural basis for discrimination of L-phenylalanine from L-tyrosine by phenylalanyl-tRNA synthetase. Structure. 2005;13(12):1799–1807.
   Web of Science ®Google Scholar
• Ibba M, Kast P, Hennecke H. Substrate specificity is determined by amino acid binding pocket size in Escherichia coli phenylalanyl-tRNA synthetase. Biochemistry. 1994;33(23):7107–7112.
   Web of Science ®Google Scholar
• Augustin S, Nolden M, Müller S, Hardt O, Arnold I, Langer T. Characterization of peptides released from mitochondria: evidence for constant proteolysis and peptide efflux. J Biol Chem. 2005;280(4):2691–2699.
   PubMed Web of Science ®Google Scholar
• Janska H, Kwasniak M, Szczepanowska J. Protein quality control in organelles -AAA/FtsH story. Biochim Biophys Acta. 2013;1833(2):381–387.
   Web of Science ®Google Scholar
• Stadtman ER. Protein oxidation and aging. Science. 1992;257(5074):1220–1224.
   PubMed Web of Science ®Google Scholar
• Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J. 1997;324(Pt 1):1–18.
   PubMed Web of Science ®Google Scholar
• Fu S, Davies MJ, Stocker R, Dean RT. Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J. 1998;333(Pt 3):519–525.
   PubMedGoogle Scholar
• Klipcan L, Moor N, Kessler N, Safro MG. Eukaryotic cytosolic and mitochondrial phenylalanyl-tRNA synthetases catalyze the charging of tRNA with the meta-tyrosine. Proc Natl Acad Sci U S A. 2009;106(27):11045–11048.
   Web of Science ®Google Scholar
• Rodgers KJ, Dean RT. Metabolism of protein-bound DOPA in mammals. Int J Biochem Cell Biol. 2000;32(9):945–955.
   Web of Science ®Google Scholar
• Lawrence AD, Evans AH, Lees AJ. Compulsive use of dopamine replacement therapy in Parkinson’s disease: reward systems gone awry? Lancet Neurol. 2003;2(10):595–604.
   PubMed Web of Science ®Google Scholar
• Nutt JG, Nygaard TG. Response to levodopa treatment in dopa-responsive dystonia. Arch Neurol. 2001;58(6):905–910.
   Google Scholar
• Malkus KA, Tsika E, Ischiropoulos H. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson’s disease: how neurons are lost in the Bermuda triangle. Mol Neurodegener. 2009;4:24.
   PubMed Web of Science ®Google Scholar
• Moor N, Klipcan L, Safro MG. Bacterial and eukaryotic phenylalanyl-tRNA synthetases catalyze misaminoacylation of tRNA(Phe) with 3,4-dihydroxy-L-phenylalanine. Chem Biol. 2011;18(10):1221–1229.
   Google Scholar
• First EA. L-DOPA ropes in tRNA(Phe). Chem Biol. 2011;18(10):1201–1202.
   Google Scholar
• Reynolds NM, Ling J, Roy H, et al. Cell-specific differences in the requirements for translation quality control. Proc Natl Acad Sci U S A. 2010;107(9):4063–4068.
   Web of Science ®Google Scholar
• Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie. 2001;83(3–4):301–310.
   PubMed Web of Science ®Google Scholar
• Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000;10(12):524–530.
   PubMed Web of Science ®Google Scholar
• Rodgers KJ, Shiozawa N. Misincorporation of amino acid analogues into proteins by biosynthesis. Int J Biochem Cell Biol. 2008;40(8):1452–1466.
   PubMed Web of Science ®Google Scholar
• Dunlop RA, Brunk UT, Rodgers KJ. Proteins containing oxidized amino acids induce apoptosis in human monocytes. Biochem J. 2011;435(1):207–216.
   Google Scholar
• Rodgers KJ, Hume PM, Morris JG, Dean RT. Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa. J Neurochem. 2006;98(4):1061–1067.
   Web of Science ®Google Scholar
• Lechler A, Kreutzer R. The phenylalanyl-tRNA synthetase specifically binds DNA. J Mol Biol. 1998;278(5):897–901.
   Web of Science ®Google Scholar
• Dou X, Limmer S, Kreutzer R. DNA-binding of phenylalanyl-tRNA synthetase is accompanied by loop formation of the double-stranded DNA. J Mol Biol. 2001;305(3):451–458.
   PubMed Web of Science ®Google Scholar
• Wilson KP, Shewchuk LM, Brennan RG, Otsuka AJ, Matthews BW. Escherichia coli biotin holoenzyme synthetase/bio repressor crystal structure delineates the biotin- and DNA-binding domains. Proc Natl Acad Sci U S A. 1992;89(19):9257–9261.
   Web of Science ®Google Scholar
• Safro M, Mosyak L. Structural similarities in the noncatalytic domains of phenylalanyl-tRNA and biotin synthetases. Protein Sci. 1995;4(11):2429–2432.
   Web of Science ®Google Scholar
• Voloshchuk N, Montclare JK. Incorporation of unnatural amino acids for synthetic biology. Mol Biosyst. 2010;6(1):65–80.
   Google Scholar
• Link AJ, Tirrell DA. Reassignment of sense codons in vivo. Methods. 2005;36(3):291–298.
   Web of Science ®Google Scholar
• Chin JW. Expanding and reprogramming the genetic code of cells and animals. Annu Rev Biochem. 2014;83:379–408.
   PubMed Web of Science ®Google Scholar
• Kwon I, Wang P, Tirrell DA. Design of a bacterial host for site-specific incorporation of p-bromophenylalanine into recombinant proteins. J Am Chem Soc. 2006;128(36):11778–11783.
   Web of Science ®Google Scholar
• Kodama K, Fukuzawa S, Sakamoto K, et al. A new protein engineering approach combining chemistry and biology, part I; site-specific incorporation of 4-iodo-L-phenylalanine in vitro by using misacylated suppressor tRNAPhe. Chembiochem. 2006;7(10):1577–1581.
   Web of Science ®Google Scholar
• Datta D, Wang P, Carrico IS, Mayo SL, Tirrell DA. A designed phenylalanyl-tRNA synthetase variant allows efficient in vivo incorporation of aryl ketone functionality into proteins. J Am Chem Soc. 2002;124(20):5652–5653.
   Web of Science ®Google Scholar
• Kwon I, Lim SI. Tailoring the substrate specificity of yeast phenylalanyl-tRNA synthetase toward a phenylalanine analog using multiple- site-specific incorporation. ACS Synth Biol. 2015;4(5):634–643.
   Web of Science ®Google Scholar
• Johnson JA, Lu YY, Van Deventer JA, Tirrell DA. Residue-specific incorporation of non-canonical amino acids into proteins: recent developments and applications. Curr Opin Chem Biol. 2010;14(6):774–780.
   PubMed Web of Science ®Google Scholar
• Chin JW, Cropp TA, Anderson JC, Mukherji M, Zhang Z, Schultz PG. An expanded eukaryotic genetic code. Science. 2003;301(5635):964–967.
   PubMed Web of Science ®Google Scholar
• Liu W, Brock A, Chen S, Chen S, Schultz PG. Genetic incorporation of unnatural amino acids into proteins in mammalian cells. Nat Methods. 2007;4(3):239–244.
   PubMed Web of Science ®Google Scholar
• Arai N, Ito T. Amino acid requirements of the silkworm, Bombyx mori L. J Sericult Sci Jpn. 1964;33:107–110.
   Google Scholar
• Zhou CZ, Confalonieri F, Medina N, et al. Fine organization of Bombyx mori fibroin heavy chain gene. Nucleic Acids Res. 2000;28(12):2413–2419.
   PubMed Web of Science ®Google Scholar
• Omenetto FG, Kaplan DL. New opportunities for an ancient material. Science. 2010;329(5991):528–531.
   PubMed Web of Science ®Google Scholar
• Kaplan D, Adams WW, Farmer B, Viney C. Silk polymers: materials science and biotechnology. ACS Symp Ser. 1994;544:291–358.
   Google Scholar
• Leal-Egaña A, Scheibel T. Silk-based materials for biomedical applications. Biotechnol Appl Biochem. 2010;55(3):155–167.
   Google Scholar
• Teramoto H, Kojima K. Cloning of Bombyx mori phenylalanyl-tRNA synthetase and the generation of its mutant with relaxed amino acid specificity. J Insect Biotechnol Sericol. 2010;79:53–65.
   Google Scholar
• Teramoto H, Kojima K, Kajiwara H, Ishibashi J. Expansion of the amino acid repertoire in protein biosynthesis in silkworm cells. Chembiochem. 2012;13(1):61–65.
   Web of Science ®Google Scholar
• Teramoto H, and Kojima K. Residue-specific incorporation of phenylalanine analogues into protein biosynthesis in silkworm cultured cells. J. Insect Biotechnol Sericol. 2013;82(3):61–69.
   Google Scholar
• Teramoto H, Kojima K. Production of Bombyx mori silk fibroin incorporated with unnatural amino acids. Biomacromolecules. 2014;15(7):2682–2690.
   Web of Science ®Google Scholar
• McDevitt D, Rosenberg M. Exploiting genomics to discover new antibiotics. Trends Microbiol. 2001;9(12):611–617.
   PubMed Web of Science ®Google Scholar
• Vondenhoff GH, Van Aerschot A. Aminoacyl-tRNA synthetase inhibitors as potential antibiotics. Eur J Med Chem. 2011;46(11):5227–5236.
   PubMed Web of Science ®Google Scholar
• Chopra I, Hesse L, O’Neill AJ. Exploiting current understanding of antibiotic action for discovery of new drugs. J Appl Microbiol. 2002;92(Suppl s1):4S–15S.
   Google Scholar
• Hurdle JG, O’Neill AJ, Chopra I. Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents. Antimicrob Agents Chemother. 2005;49(12):4821–4833.
   PubMed Web of Science ®Google Scholar
• Yu XY, Finn J, Hill JM, et al. A series of spirocyclic analogues as potent inhibitors of bacterial phenylalanyl-tRNA synthetases. Bioorg Med Chem Lett. 2004;14(5):1339–1342.
   Web of Science ®Google Scholar
• Yu XY, Finn J, Hill JM, et al. A series of heterocyclic inhibitors of phenylalanyl-tRNA synthetases with antibacterial activity. Bioorg Med Chem Lett. 2004;14(5):1343–1346.
   Web of Science ®Google Scholar
• Jarvest RL, Erskine SG, Forrest AK, et al. Discovery and optimisation of potent, selective, ethanolamine inhibitors of bacterial phenylalanyl tRNA synthetase. Bioorg Med Chem Lett. 2005;15(9):2305–2309.
   Web of Science ®Google Scholar
• Montgomery JI, Toogood PL, Hutchings KM, et al. Discovery and SAR of benzyl phenyl ethers as inhibitors of bacterial phenylalanyl-tRNA synthetase. Bioorg Med Chem Lett. 2009;19(3):665–669.
   Web of Science ®Google Scholar
• Beyer D, Kroll HP, Endermann R, et al. New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity. Antimicrob Agents Chemother. 2004;48(2):525–532.
   PubMed Web of Science ®Google Scholar
• Abibi A, Ferguson AD, Fleming PR, et al. The role of a novel auxiliary pocket in bacterial phenylalanyl-tRNA synthetase druggability. J Biol Chem. 2014;289(31):21651–21662.
   Web of Science ®Google Scholar
• Bonnefond L, Fender A, Rudinger-Thirion J, Giegé R, Florentz C, Sissler M. Toward the full set of human mitochondrial aminoacyl-tRNA synthetases: characterization of AspRS and TyrRS. Biochemistry. 2005;44(12):4805–4816.
   Web of Science ®Google Scholar
• Park SG, Schimmel P, Kim S. Aminoacyl tRNA synthetases and their connections to disease. Proc Natl Acad Sci U S A. 2008;105(32):11043–11049.
   Web of Science ®Google Scholar
• Elo JM, Yadavalli SS, Euro L, et al. Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum Mol Genet. 2012;21(20):4521–4529.
   PubMed Web of Science ®Google Scholar
• Shamseldin HE, Alshammari M, Al-Sheddi T, et al. Genomic analysis of mitochondrial diseases in a consanguineous population reveals novel candidate disease genes. J Med Genet. 2012;49(4):234–241.
   Web of Science ®Google Scholar
• Almalki A, Alston CL, Parker A, et al. Mutation of the human mitochondrial phenylalanine-tRNA synthetase causes infantile-onset epilepsy and cytochrome c oxidase deficiency. Biochim Biophys Acta. 2014;1842(1):56–64.
   Web of Science ®Google Scholar
• Vernon HJ, McClellan R, Batista DA, Naidu S. Mutations in FARS2 and non-fatal mitochondrial dysfunction in two siblings. Am J Med Genet A. 2015;167A(5):1147–1151.
   Google Scholar
• Banerjee R, Reynolds NM, Yadavalli SS, et al. Mitochondrial aminoacyl-tRNA synthetase single-nucleotide polymorphisms that lead to defects in refolding but not aminoacylation. J Mol Biol. 2011;410(2):280–293.
   Web of Science ®Google Scholar
• Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N. Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology. 2007;46(6):1005–1008.
   Web of Science ®Google Scholar
• Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum. 1980;23(8):881–888.
   PubMed Web of Science ®Google Scholar
• Mathews MB, Reichlin M, Hughes GR, Bernstein RM. Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. J Exp Med. 1984;160(2):420–434.
   PubMed Web of Science ®Google Scholar
• Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J Exp Med. 1986;163(5):1281–1291.
   PubMed Web of Science ®Google Scholar
• Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol. 1990;144(5):1737–1743.
   PubMed Web of Science ®Google Scholar
• Hirakata M, Suwa A, Nagai S, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol. 1999;162(4):2315–2320.
   PubMed Web of Science ®Google Scholar
• Hashish L, Trieu EP, Sadanandan P, Targoff IN. Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with antisynthetase syndrome. Arthritis Rheum. 2005;52(Suppl 9):S312.
   Google Scholar
• Yuet KP, Doma MK, Ngo JT, et al. Cell-specific proteomic analysis in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2015;112(9):2705–2710.
   Web of Science ®Google Scholar
• Miyazaki K. Molecular engineering of a PheS counterselection marker for improved operating efficiency in Escherichia coli. Biotechniques. 2015;58(2):86–88.
   Google Scholar
• Carr JF, Danziger ME, Huang AL, Dahlberg AE, Gregory ST. Engineering the genome of Thermus thermophilus using a counter selectable marker. J Bacteriol. 2015;197(6):1135–1144.
   Web of Science ®Google Scholar
• Lu J, Bergert M, Walther A, Suter B. Double-sieving-defective aminoacyl-tRNA synthetase causes protein mistranslation and affects cellular physiology and development. Nat Commun. 2014;5:5650.
   PubMed Web of Science ®Google Scholar